Colistin Methanesulfonate and Colistin Pharmacokinetics in Critically Ill Patients Receiving Continuous Venovenous Hemodiafiltration

This report describes the pharmacokinetics of colistin methanesulfonate (CMS) and colistin in five intensive care unit patients receiving continuous venovenous hemodiafiltration. For CMS, the mean maximum concentration of drug in plasma (C(max)) after the fourth dose was 6.92 mg/liter and total clea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Karvanen, Matti, Plachouras, Diamantis, Friberg, Lena E., Paramythiotou, Elisabeth, Papadomichelakis, Evangelos, Karaiskos, Ilias, Tsangaris, Iraklis, Armaganidis, Apostolos, Cars, Otto, Giamarellou, Helen
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2013
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3535942/
https://ncbi.nlm.nih.gov/pubmed/23147733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00985-12
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars